RecruitingPhase 3NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Sponsor: AstraZeneca
Boca Raton, FL · Fort Lauderdale, FL · +13 more sites